Bronchodilators for treating obstructive lung disease
US12257248B2 · kind B2 · utility
0Cited by
4References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 1, 2021 |
| Grant date | Mar 25, 2025 |
| Priority date | — |
| Expiry date | Oct 4, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/444
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are compounds useful for treating obstructive lung diseases. The compounds are TAS2Rs agonists and may further be used to treat disorders and conditions implicated by TAS2R. In some instances the disclosed compounds can be used to treat asthma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.